However, Wang et al. [17] demonstrated an indirect correlation between CXCL10 and IL-18 changes after ICI treatment, but, differently from us, they analysed a whole cohort of NSCLC patients treated with ICI regardless the presence and/or severity of irAEs. This evidence concerns the gene IL18 and non-small cell lung carcinoma.